Mesa Laboratories, Inc.
MLAB
$107.64
$1.601.51%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.00% | 2.56% | 3.64% | 5.02% | 2.36% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.00% | 2.56% | 3.64% | 5.02% | 2.36% |
| Cost of Revenue | -6.54% | -9.29% | 1.06% | 6.76% | 12.22% |
| Gross Profit | 5.61% | 9.87% | 5.13% | 3.96% | -2.86% |
| SG&A Expenses | -5.66% | 7.42% | -0.45% | 0.90% | 7.27% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.97% | 0.51% | 0.16% | 3.98% | 9.01% |
| Operating Income | 129.47% | 87.07% | 38.00% | 19.23% | -51.81% |
| Income Before Tax | -37.92% | -445.55% | 307.31% | -47.56% | 79.56% |
| Income Tax Expenses | -32.91% | -66.43% | 278.56% | -224.22% | 339.07% |
| Earnings from Continuing Operations | -40.32% | 41.86% | 316.59% | -27.77% | 39.96% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -40.32% | 41.86% | 316.59% | -27.77% | 39.96% |
| EBIT | 129.47% | 87.07% | 38.00% | 19.23% | -51.81% |
| EBITDA | 40.52% | -5.22% | 21.41% | 5.41% | -23.70% |
| EPS Basic | -42.34% | 42.97% | 312.57% | -29.07% | 38.21% |
| Normalized Basic EPS | -40.03% | -438.87% | 303.49% | -53.98% | 285.53% |
| EPS Diluted | -42.35% | 42.97% | 309.68% | -28.70% | 37.10% |
| Normalized Diluted EPS | -40.12% | -438.87% | 302.27% | -53.68% | 281.26% |
| Average Basic Shares Outstanding | 3.51% | 1.93% | 1.90% | 1.83% | 1.26% |
| Average Diluted Shares Outstanding | 3.67% | 1.93% | 2.51% | 1.17% | 2.38% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 0.70% | -0.75% | 1.47% | 0.41% | -0.28% |